Clinical trials
Completed Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
176 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 4 |
| 2002 | 5 |
| 2003 | 7 |
| 2004 | 8 |
| 2005 | 8 |
| 2006 | 11 |
| 2007 | 11 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 16 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 6 |
| 2014 | 11 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 176 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 14 |
| Fred Hutchinson Cancer Center | 10 |
| M.D. Anderson Cancer Center | 6 |
| H. Lee Moffitt Cancer Center and Research Institute | 5 |
| Millennium Pharmaceuticals, Inc. | 5 |
| European Myeloma Network B.V. | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| University of Michigan Rogel Cancer Center | 4 |
| Amgen | 3 |
| Celgene | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 176 |
| Neoplasms, Plasma Cell | 36 |
| Hodgkin Disease | 30 |
| Lymphoma, Non-Hodgkin | 30 |
| Leukemia | 24 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 24 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 24 |
| Lymphoma | 23 |
| Leukemia, Myeloid, Acute | 22 |
| Recurrence | 21 |
Trials
Showing 1 to 25 of 176. Each trial links to its page on Pharma Observatory.
76 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.